Report

Strategy for successful urine sample preparation for LC-MS/MS device at drug verification laboratory

Volume: 3 Number: 2 September 16, 2022
EN

Strategy for successful urine sample preparation for LC-MS/MS device at drug verification laboratory

Abstract

Objectives The use of liquid chromatography with tandem mass spectrometry (LC-MS/MS) device has increased significantly in toxicology validation laboratories in recent years. The maintenance cost of this expensive equipment is high as well as the cost of consumables. Reduction of the matrix effect and preparation more clear samples are very important for the validation of methods in clinical laboratories. The primary goal is to create a cleaner urine sample preparation technique to reduce the cost of maintenance of the LC-MS/MS device without affecting test results. Methods We prepared the patients’ urine in two different ways; routine urine preparation method and used our centrifuged method (14000 rpm, 10 minutes) for routine illicit substance use. The standard material used to determine whether there was a statistical difference in the urine sample with both different methods was added to both urine samples. Results Our findings showed that there was no statistical difference between the results of both methods for detection of illicit substance use. There was no difference between the high and low quantities of the 14 illicit substances measured and the centrifuged method and routine urine preparation methods (p<0.05). However, the urine sample obtained by our newly developed centrifuged method was cleaner, lucid and homogeneous. Conclusion Preliminary studies show that although the new centrifuged method is time-consuming, it can be reliable. The long-term use of this centrifugal method can reduce the costs of device maintenance, repair and consumption. So initial findings suggest that column costs and replacement processes may be positively affected.

Keywords

References

  1. Verplaetse R, Henion J. Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on-line SPE-LC-MS/MS. Drug Test Anal 2016;8:30-8.
  2. Verplaetse R, Tytgat J. Development and validation of a sensitive ultra-performance liquid chromatography tandem mass spectrometry method for the analysis of fentanyl and its major metabolite norfentanyl in urine and whole blood in forensic context. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:1987-96.
  3. Mareck U, Haenelt N, Geyer H, Guddat S, Kamber M, Brenneisen R, Thevis M, Schänzer W. Temporal indication of cannabis use by means of THC glucuronide determination. Drug Test Anal 2009;1:505-10.
  4. Henion J, Brewer E, Rule G. Peer Reviewed: Sample Preparation for LC/MS/MS: Analyzing Biological and Environmental Samples. Analytical Chemistry 1998;70:650A-656A.
  5. Felli M, Martello S, Chiarotti M. LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests. Forensic Sci Int 2011;204:67-73.
  6. Andersson M, Scheidweiler KB, Sempio C, Barnes AJ, Huestis MA. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips. Anal Bioanal Chem 2016;408:6461-71.
  7. Andersson M, Scheidweiler KB, Sempio C, Barnes AJ, Huestis MA. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips. Anal Bioanal Chem 2016;408:6461-71.
  8. Raćkowska E, Bobrowska-Korczak B, Giebułtowicz J. Development and validation of a rapid LC-MS/MS method for determination of methylated nucleosides and nucleobases in urine. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1128:121775.

Details

Primary Language

English

Subjects

Biochemistry and Cell Biology (Other)

Journal Section

Report

Publication Date

September 16, 2022

Submission Date

November 9, 2020

Acceptance Date

March 8, 2022

Published in Issue

Year 2022 Volume: 3 Number: 2

APA
Eren, E., Göncü Sürü, A., Yılmaz, N., & Öz, C. (2022). Strategy for successful urine sample preparation for LC-MS/MS device at drug verification laboratory. New Trends in Medicine Sciences, 3(2), 91-97. https://doi.org/10.56766/ntms.823790
AMA
1.Eren E, Göncü Sürü A, Yılmaz N, Öz C. Strategy for successful urine sample preparation for LC-MS/MS device at drug verification laboratory. New Trend Med Sci. 2022;3(2):91-97. doi:10.56766/ntms.823790
Chicago
Eren, Esin, Asuman Göncü Sürü, Necat Yılmaz, and Cemile Öz. 2022. “Strategy for Successful Urine Sample Preparation for LC-MS MS Device at Drug Verification Laboratory”. New Trends in Medicine Sciences 3 (2): 91-97. https://doi.org/10.56766/ntms.823790.
EndNote
Eren E, Göncü Sürü A, Yılmaz N, Öz C (September 1, 2022) Strategy for successful urine sample preparation for LC-MS/MS device at drug verification laboratory. New Trends in Medicine Sciences 3 2 91–97.
IEEE
[1]E. Eren, A. Göncü Sürü, N. Yılmaz, and C. Öz, “Strategy for successful urine sample preparation for LC-MS/MS device at drug verification laboratory”, New Trend Med Sci, vol. 3, no. 2, pp. 91–97, Sept. 2022, doi: 10.56766/ntms.823790.
ISNAD
Eren, Esin - Göncü Sürü, Asuman - Yılmaz, Necat - Öz, Cemile. “Strategy for Successful Urine Sample Preparation for LC-MS MS Device at Drug Verification Laboratory”. New Trends in Medicine Sciences 3/2 (September 1, 2022): 91-97. https://doi.org/10.56766/ntms.823790.
JAMA
1.Eren E, Göncü Sürü A, Yılmaz N, Öz C. Strategy for successful urine sample preparation for LC-MS/MS device at drug verification laboratory. New Trend Med Sci. 2022;3:91–97.
MLA
Eren, Esin, et al. “Strategy for Successful Urine Sample Preparation for LC-MS MS Device at Drug Verification Laboratory”. New Trends in Medicine Sciences, vol. 3, no. 2, Sept. 2022, pp. 91-97, doi:10.56766/ntms.823790.
Vancouver
1.Esin Eren, Asuman Göncü Sürü, Necat Yılmaz, Cemile Öz. Strategy for successful urine sample preparation for LC-MS/MS device at drug verification laboratory. New Trend Med Sci. 2022 Sep. 1;3(2):91-7. doi:10.56766/ntms.823790

Cited By